NetworkNewsBreaks – Avricore Health Inc. (TSX.V:
Post# of 61
(Total Views: 237)
Posted On: 12/22/2021 4:43:40 PM
NetworkNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Committed to Creating World’s Largest Rapid Testing Network in Pharmacy
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a point-of-care health testing technology innovator, has rolled out its trademarked HealthTab(TM) platform in select Ontario and British Columbia Shoppers Drug Mart network pharmacies. The company continues to add lab-accurate test functionality to its kiosks, most recently announcing a solution for monitoring kidney function. Already, Avricore has agreements with Abbott Laboratories currently in the pilot stage that allow for the testing of markers related to conditions such as diabetes, heart disease and viruses such as SARS-CoV-2, RSV, influenza A and B, and strep, empowering patients who want to take a greater role in managing their conditions. “Avricore’s purpose is to likewise empower community pharmacies, particularly those in Canada whose revenues were impacted by the Pan-Canadian Select Molecule Price Initiative for Generic Drugs in 2018 that reduced retail margins in reimbursements,” reads a recent article. “We’ve demonstrated a unique resilience by remaining focused on our goal of creating the world’s largest rapid testing network in pharmacy,” Avricore CEO Hector Bremner stated earlier this year. “We are well on our way to making actionable health information more accessible for everyone and dramatically expanding our network in the coming months.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a point-of-care health testing technology innovator, has rolled out its trademarked HealthTab(TM) platform in select Ontario and British Columbia Shoppers Drug Mart network pharmacies. The company continues to add lab-accurate test functionality to its kiosks, most recently announcing a solution for monitoring kidney function. Already, Avricore has agreements with Abbott Laboratories currently in the pilot stage that allow for the testing of markers related to conditions such as diabetes, heart disease and viruses such as SARS-CoV-2, RSV, influenza A and B, and strep, empowering patients who want to take a greater role in managing their conditions. “Avricore’s purpose is to likewise empower community pharmacies, particularly those in Canada whose revenues were impacted by the Pan-Canadian Select Molecule Price Initiative for Generic Drugs in 2018 that reduced retail margins in reimbursements,” reads a recent article. “We’ve demonstrated a unique resilience by remaining focused on our goal of creating the world’s largest rapid testing network in pharmacy,” Avricore CEO Hector Bremner stated earlier this year. “We are well on our way to making actionable health information more accessible for everyone and dramatically expanding our network in the coming months.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Avricore Health Inc. (AVCRF) Stock Research Links
Scroll down for more posts ▼